Immunohistochemical and genetic evaluation of double-hit lymphomas Read more about Immunohistochemical and genetic evaluation of double-hit lymphomas
Correlation of MYC rearrangement with MYC immunohistochemistry in aggressive B-cell lymphomas Read more about Correlation of MYC rearrangement with MYC immunohistochemistry in aggressive B-cell lymphomas
Aggressive B-cell lymphomas of the respiratory system: histologic, immunohistochemical and genetic evaluation of a large series Read more about Aggressive B-cell lymphomas of the respiratory system: histologic, immunohistochemical and genetic evaluation of a large series
Aggressive B-cell lymphoma in extreme age groups; Review of a series of 760 cases Read more about Aggressive B-cell lymphoma in extreme age groups; Review of a series of 760 cases
MultiOmyx™ multiplexed tumor infiltrating lymphocyte panel provides comprehensive immunophenotyping from a single FFPE slide Read more about MultiOmyx™ multiplexed tumor infiltrating lymphocyte panel provides comprehensive immunophenotyping from a single FFPE slide
Detection of IFNγ induced PD-L1 expression by combined in situ RNA analysis and protein profiling from a single FFPE slide Read more about Detection of IFNγ induced PD-L1 expression by combined in situ RNA analysis and protein profiling from a single FFPE slide
PD-L1 expression correlates with TP53 gene mutation status in lung cancer but not in colorectal cancer Read more about PD-L1 expression correlates with TP53 gene mutation status in lung cancer but not in colorectal cancer
MLL: The gene and its translocation partners. 2 cases with a t(11;17) involving MLL and mimicking the variant t(11;17) RARA translocation Read more about MLL: The gene and its translocation partners. 2 cases with a t(11;17) involving MLL and mimicking the variant t(11;17) RARA translocation
Using next generation sequencing of peripheral blood cfDNA as a clinical test in screening for hematologic neoplasms Read more about Using next generation sequencing of peripheral blood cfDNA as a clinical test in screening for hematologic neoplasms
Interclonal and intraclonal heterogeneity in patients with IDH1/2 mutation Read more about Interclonal and intraclonal heterogeneity in patients with IDH1/2 mutation